Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rieckmann

Showing results (21-30 of 142) with videos related to

Pageof 15
Sort By:
Analytical Biochemistry|July 1, 1997
Isolation of cytoplasmic RNA from small samples of whole bloodU Michel, A Rau, P Rieckmann
Biochemical and Biophysical Research Communications|August 31, 1992
Okadaic acid is a potent inducer of AP-1, NF-kappa B, and tumor necrosis factor-alpha in human B lymphocytesP Rieckmann, C Thévenin, J H Kehrl
Schmerz (Berlin, Germany)|October 12, 2012
[Central pain processing and Parkinson's disease. Epidemiology, physiology, and experimental results issuing pain processing]J A Priebe, P Rieckmann, S Lautenbacher
European Neurology|September 13, 2006
Symptomatic treatment of multiple sclerosis. Multiple Sclerosis Therapy Consensus Group (MSTCG) of the German Multiple Sclerosis SocietyT Henze, P Rieckmann, K V Toyka, et al.
Journal of Virology|January 1, 1994
Regulation of JC virus expression in B lymphocytesP Rieckmann, U Michel, J H Kehrl
Journal of Immunological Methods|March 31, 1998
Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen bloodN Kruse, M Pette, K Toyka, et al.
Journal of Periodontal Research|July 17, 2001
Genetic polymorphism of the tumor necrosis factor (TNF)-alpha promoter region in families with localized early-onset periodontitisL Shapira, A Stabholz, P Rieckmann, et al.
Neurology|August 1, 1996
The phosphodiesterase inhibitor pentoxifylline reduces early side effects of interferon-beta 1b treatment in patients with multiple sclerosisP Rieckmann, F Weber, A Günther, et al.
Methods (San Diego, Calif.)|January 1, 1997
Tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in B-lymphocyte functionP Rieckmann, J M Tuscano, J H Kehrl
Der Nervenarzt|January 16, 2002
[Comment on the contribution by F. Zipp and K. P. Wandinger. Current recommendations for vaccinations in multiple sclerosis]P Rieckmann, N Moriabadi, P Flachenecker, et al.
Pageof 15

Showing results (21-30 of 142) with videos related to

Sort By:
Pageof 15
Analytical Biochemistry|July 1, 1997
Isolation of cytoplasmic RNA from small samples of whole bloodU Michel, A Rau, P Rieckmann
Biochemical and Biophysical Research Communications|August 31, 1992
Okadaic acid is a potent inducer of AP-1, NF-kappa B, and tumor necrosis factor-alpha in human B lymphocytesP Rieckmann, C Thévenin, J H Kehrl
Schmerz (Berlin, Germany)|October 12, 2012
[Central pain processing and Parkinson's disease. Epidemiology, physiology, and experimental results issuing pain processing]J A Priebe, P Rieckmann, S Lautenbacher
European Neurology|September 13, 2006
Symptomatic treatment of multiple sclerosis. Multiple Sclerosis Therapy Consensus Group (MSTCG) of the German Multiple Sclerosis SocietyT Henze, P Rieckmann, K V Toyka, et al.
Journal of Virology|January 1, 1994
Regulation of JC virus expression in B lymphocytesP Rieckmann, U Michel, J H Kehrl
Journal of Immunological Methods|March 31, 1998
Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen bloodN Kruse, M Pette, K Toyka, et al.
Journal of Periodontal Research|July 17, 2001
Genetic polymorphism of the tumor necrosis factor (TNF)-alpha promoter region in families with localized early-onset periodontitisL Shapira, A Stabholz, P Rieckmann, et al.
Neurology|August 1, 1996
The phosphodiesterase inhibitor pentoxifylline reduces early side effects of interferon-beta 1b treatment in patients with multiple sclerosisP Rieckmann, F Weber, A Günther, et al.
Methods (San Diego, Calif.)|January 1, 1997
Tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in B-lymphocyte functionP Rieckmann, J M Tuscano, J H Kehrl
Der Nervenarzt|January 16, 2002
[Comment on the contribution by F. Zipp and K. P. Wandinger. Current recommendations for vaccinations in multiple sclerosis]P Rieckmann, N Moriabadi, P Flachenecker, et al.
Pageof 15